Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!

blood disorders

Nov 07, 2022

Roche’s HEMLIBRA: A Game Changer in Hemophilia A Treatment Landscape

Feb 08, 2022

Biogen’s Aduhelm; FDA Approves Sanofi’s Enjaymo; NHS & Orchard Signs a Deal; Bristol’s Breyanzi & Abecma; Pharming’s Leniolisib; Eli Lilly’s Verzenio Trial; UCB’ Zilucoplan Trials Result; Eli Lilly’s Alzheimer’s Drug Donanemab

Nov 13, 2019

Beta-Thalassemia Pharmacological Therapies

Newsletter/Whitepaper